Modulus Discovery Announces the Appointment of Hiroko Nishimoto As Advisor

Modulus Discovery, Inc., an early stage global biopharmaceutical company, announced today the appointment of Hiroko Nishimoto as Advisor to the Company.

Ms. Nishimoto has more than 14 years of pharmaceutical business experience including corporate strategy, business development, external affairs, and CSR at Astellas Pharma Inc.. As a liaison of the Japan Pharmaceutical Manufacturers Association, she has been seconded to the International Federation of Pharmaceutical Manufacturers & Associations, (IFPMA) at Geneva, Switzerland. She worked to create synergies across the public and private sectors in global health policy and form partnerships with United Nation agencies, governments, NGOs, and industry associations. Ms. Nishimoto will provide advice on global business development and international regulation of pharmaceuticals.

Comment from S. Roy Kimura, CEO of Modulus Discovery, Inc.:

“We are honored to welcome Ms. Nishimoto as Advisor to Modulus. Ms. Nishimoto has extensive knowledge of the global pharmaceutical business and we are excited to benefit from her expertise to accelerate our global business development.”

Comment from Ms. Nishimoto:
“As Advisor, I am excited to join Modulus Discovery which has developed an unique business model. I look forward to working closely with them to accelerate its global business development and sustainably enhance their corporate value.”


If you’d like more information about this topic, please email at

Modulus Discovery Announces the Appointment of Hiroko Nishimoto As Advisor